267 related articles for article (PubMed ID: 28713676)
21. Immunotherapy strategies for mesothelioma - the role of tumor specific neoantigens in a new era of precision medicine.
Ye L; Ma S; Robinson BW; Creaney J
Expert Rev Respir Med; 2019 Feb; 13(2):181-192. PubMed ID: 30596292
[TBL] [Abstract][Full Text] [Related]
22. Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights.
López-Castro R; Fuentes-Martín Á; Medina Del Valle A; García Peña T; Soro García J; López González L; Cilleruelo Ramos Á
Open Respir Arch; 2024; 6(3):100323. PubMed ID: 38660145
[TBL] [Abstract][Full Text] [Related]
23. Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
Guazzelli A; Bakker E; Tian K; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Opin Investig Drugs; 2017 Aug; 26(8):933-944. PubMed ID: 28679291
[TBL] [Abstract][Full Text] [Related]
24. Novel intrapleural therapies for malignant diseases.
Haas AR; Sterman DH
Respiration; 2012; 83(4):277-92. PubMed ID: 22456231
[TBL] [Abstract][Full Text] [Related]
25. [Current insights in malignant pleural mesothelioma].
Bard M; Debrosse D; Caliandro R; Girard P; Grunenwald D; Ruffié P
Bull Cancer; 2002 Jan; 89(1):67-74. PubMed ID: 11847028
[TBL] [Abstract][Full Text] [Related]
26. Advances in the treatment of malignant pleural mesothelioma.
Sterman DH; Kaiser LR; Albelda SM
Chest; 1999 Aug; 116(2):504-20. PubMed ID: 10453882
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy in malignant pleural mesothelioma: a review of literature data.
Menis J; Pasello G; Remon J
Transl Lung Cancer Res; 2021 Jun; 10(6):2988-3000. PubMed ID: 34295692
[TBL] [Abstract][Full Text] [Related]
28. New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.
Kotova S; Wong RM; Cameron RB
Cancer Manag Res; 2015; 7():51-63. PubMed ID: 25670913
[TBL] [Abstract][Full Text] [Related]
29. Novel systemic therapy against malignant pleural mesothelioma.
Mancuso MR; Neal JW
Transl Lung Cancer Res; 2017 Jun; 6(3):295-314. PubMed ID: 28713675
[TBL] [Abstract][Full Text] [Related]
30. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T
Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.
Tsao AS; Mehran R; Roth JA
Clin Lung Cancer; 2009 Jan; 10(1):36-41. PubMed ID: 19289370
[TBL] [Abstract][Full Text] [Related]
32. Oncolytic Viral Therapy for Mesothelioma.
Pease DF; Kratzke RA
Front Oncol; 2017; 7():179. PubMed ID: 28884088
[TBL] [Abstract][Full Text] [Related]
33. New horizons from immunotherapy in malignant pleural mesothelioma.
Calabrò L; Rossi G; Maio M
J Thorac Dis; 2018 Jan; 10(Suppl 2):S322-S332. PubMed ID: 29507802
[TBL] [Abstract][Full Text] [Related]
34. Malignant pleural mesothelioma.
Chen SE; Pace MB
Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
[TBL] [Abstract][Full Text] [Related]
35. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
Sterman DH; Albelda SM
Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137
[TBL] [Abstract][Full Text] [Related]
36. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.
Zhang W; Wu X; Wu L; Zhang W; Zhao X
Ann Transl Med; 2015 Aug; 3(13):182. PubMed ID: 26366399
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report.
Xuan TT; Li GY; Meng SB; Wang ZM; Qu LL
World J Clin Cases; 2022 Aug; 10(23):8284-8290. PubMed ID: 36159517
[TBL] [Abstract][Full Text] [Related]
38. Treatment of malignant mesothelioma.
Jaklitsch MT; Grondin SC; Sugarbaker DJ
World J Surg; 2001 Feb; 25(2):210-7. PubMed ID: 11338024
[TBL] [Abstract][Full Text] [Related]
39. Malignant pleural mesothelioma.
Boutin C; Schlesser M; Frenay C; Astoul P
Eur Respir J; 1998 Oct; 12(4):972-81. PubMed ID: 9817178
[TBL] [Abstract][Full Text] [Related]
40. Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.
Al-Taei S; Salimu J; Lester JF; Linnane S; Goonewardena M; Harrop R; Mason MD; Tabi Z
Lung Cancer; 2012 Aug; 77(2):312-8. PubMed ID: 22498111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
